Suzhou Ryway Biotech Co., Ltd, founded in 2016 and based in Xiangcheng, Suzhou, is a manufacturer and exporter of active pharmaceutical ingredients and pharmaceutical intermediates. Its portfolio spans generic APIs across antiviral, antibiotic, CNS, and cardiovascular categories (including Baloxavir Marboxil, Dolutegravir, Sofosbuvir, Brivaracetam, Vortioxetine, and Argatroban), radiographic contrast media such as Iohexol, Iopamidol, and Iodixanol, metabolic peptides like Semaglutide and Tirzepatide, and taxane-related intermediates such as 10-deacetylbaccatin III and 7-troc paclitaxel. The company offers CRO and CMO contract services, ships on FOB, CFR, CIF, CIP, and CPT terms, and sells into Western Europe, Eastern Europe, and Asia, citing its brand and production capacity as core strengths.
No comments available.
Leave your rating & comment